Cldn34d Inhibitors refers to a diverse group of chemicals that can indirectly affect the function of the protein claudin 34D (CLDN34D). These compounds interact with various cellular pathways and structures that are associated with the regulation and maintenance of tight junctions, of which CLDN34D is an integral component. The integrity and function of tight junctions are critical for their role in controlling paracellular transport and maintaining cell polarity.
Chemicals such as CPE and WGA can directly bind to claudins, potentially altering the function of CLDN34D within tight junctions. Compounds that affect the redox state of cells, such as DTT, or the glycosylation status, such as tunicamycin, can modify the structure and function of membrane proteins including CLDN34D. Calcium chelators like EGTA can disrupt calcium-dependent interactions that are necessary for tight junction stability, thereby potentially affecting CLDN34D's role in these structures. Inhibitors of signaling molecules and pathways, such as Y-27632, forskolin, calyculin A, chelerythrine, gefitinib, and staurosporine, can lead to changes in tight junction assembly, disassembly, or function, thereby indirectly influencing the role of CLDN34D. Amiloride's action on transcellular transport can lead to changes in the cellular ionic environment, which can have a downstream effect on tight junction dynamics and the functioning of CLDN34D.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $21.00 $65.00 $120.00 $251.00 $815.00 | 23 | |
Calcium chelator that can disrupt calcium-dependent interactions in tight junctions, potentially affecting CLDN34D. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that can alter actomyosin contraction, potentially influencing tight junctions and CLDN34D. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibitor of N-linked glycosylation, can disrupt membrane protein processing, affecting CLDN34D. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Protein phosphatase inhibitor that can affect tight junction phosphorylation status, potentially affecting CLDN34D. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
PKC inhibitor that can alter tight junction assembly and function, potentially affecting CLDN34D. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR tyrosine kinase inhibitor that can affect cell signaling pathways related to tight junctions, potentially influencing CLDN34D. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Kinase inhibitor that can broadly affect cell signaling, potentially influencing tight junctions and CLDN34D. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Sodium channel blocker that can affect transcellular transport, potentially influencing paracellular tight junctions and CLDN34D. | ||||||